Patterns of Medication Use in Systemic Lupus Erythematosus - A Multi-Centre Cohort Study.
Rangi Kandane-RathnayakeWorawit LouthrenooShue-Fen LuoYeong-Jian J WuYi-Hsing ChenVera GolderAisha LateefJiacai ChoSandra V NavarraLeonid ZamoraLaniyati HamijoyoSargunan SockalingamYuan AnZhanguo LiRicardo MontesShereen OonYasuhiro KatsumataMasayoshi HarigaiYanjie HaoZhuoli ZhangMadelynn ChanJun KikuchiTsutomu TakeuchiFiona GoldblattSean O'NeillSang-Cheol BaeChak S LauAlberta HoiChetan S KaryekarMandana NikpourEric F Morandnull nullPublished in: Arthritis care & research (2021)
Most patients received combination treatment. GC persistence was high, while IS persistence was low. Patients with high disease activity received more medication combinations but had reduced IS persistence, consistent with limited utility. These data confirm unmet need for improved SLE treatments.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- end stage renal disease
- ankylosing spondylitis
- chronic kidney disease
- newly diagnosed
- juvenile idiopathic arthritis
- healthcare
- peritoneal dialysis
- big data
- emergency department
- machine learning
- mass spectrometry
- smoking cessation